1. Home
  2. KVHI vs UNCY Comparison

KVHI vs UNCY Comparison

Compare KVHI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$7.17

Market Cap

130.8M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$4.80

Market Cap

150.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
UNCY
Founded
1978
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.8M
150.1M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
KVHI
UNCY
Price
$7.17
$4.80
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
104.4K
735.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
0.04
N/A
Revenue
$9,622,000.00
$675,000.00
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
$582.86
P/E Ratio
$180.00
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$3.72
52 Week High
$13.00
$8.74

Technical Indicators

Market Signals
Indicator
KVHI
UNCY
Relative Strength Index (RSI) 41.34 39.00
Support Level $6.90 $3.93
Resistance Level $7.74 $5.86
Average True Range (ATR) 0.29 0.21
MACD 0.05 -0.04
Stochastic Oscillator 43.86 10.08

Price Performance

Historical Comparison
KVHI
UNCY

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: